Related by context. Frequent words. (Click for all words.) 72 Initiates Phase II 70 Daclizumab 70 IMC #B 70 R sorafenib tablets 70 Receives Orphan Drug Designation 69 proteasome inhibitor 69 Meets Primary Endpoint 69 refractory chronic lymphocytic 69 Nexavar ® 69 IMC A# 68 Phase Ib II 68 Drug Candidate 68 ixabepilone 68 Presents Positive 67 elotuzumab 67 HGS ETR2 67 drug conjugate 67 Clinical Trial Results 67 Small Molecule 67 Commences Phase 67 Pralatrexate 67 SAR# [004] 67 Copegus R 67 Patient Enrollment 67 Completes Enrollment 67 pertuzumab 67 liposomal formulation 66 JAK inhibitor 66 Pivotal Study 66 Ixempra 66 Initiate Phase 66 Pivotal Phase III 66 Epidermal Growth Factor Receptor 66 Epratuzumab 66 MKC# 66 Pivotal Phase 66 multi kinase inhibitor 66 Dapagliflozin 66 Panzem R 66 FDA Accepts 65 Recombinant Human 65 Monoclonal Antibody 65 TLR9 agonists 65 deforolimus 65 Vytorin combines 65 Urocidin 65 GVAX R 65 Phase III Clinical Trial 65 AEG# 65 PEG SN# 65 Zolinza 65 Palifosfamide 65 Preclinical Data 65 metastatic hormone refractory 65 CDP# 65 Amrubicin 65 Aliskiren 65 Tesetaxel 65 Cetrorelix 65 Phase III Trial 65 targeting CD# 65 Drug Shows Promise 65 Ambrisentan 65 Panitumumab 65 CCX# 64 Develop Novel 64 Allovectin 7 ® 64 optical biosensors 64 ThermoDox R 64 Pivotal Trial 64 Factor VIIa 64 ASONEP 64 Initiates Phase 64 ATL# [001] 64 phase IIb clinical 64 Allovectin 7 R 64 anti CD# monoclonal 64 Alemtuzumab 64 Carfilzomib 64 Erlotinib 64 phase Ib 64 MORAb 64 vismodegib 64 Voreloxin 64 tanespimycin 64 Vaccinex 64 Proxinium TM 63 Cancer Vaccines 63 Pfizer Sutent 63 sunitinib malate 63 Azedra 63 cancer immunotherapies 63 AVE# 63 lung pancreatic 63 KNS # 63 AzaSite Plus 63 GRNVAC1 63 Ofatumumab 63 Gemzar ® 63 Laquinimod 63 metastatic castration resistant